Orphan Drug Exclusivity: How Rare-Disease Medicines Get Market Protection
Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits were once impossible. Since 1983, over 1,000 such drugs have reached patients - but debates over pricing and abuse continue.
1 Feb 2026